Nestlé has expanded a recall of infant formula products across Europe after identifying a potential food safety risk. The company pulled specific batches of SMA, BEBA, and NAN infant and follow-on formula from store shelves. The recall aims to protect infants from possible health effects linked to a toxin.
The action began in December on a limited scale. However, Nestlé later broadened the recall after reviewing additional data. This development arrives during a challenging period for the company, as new leadership works to restore growth and stability.
Nestlé confirmed that no illnesses have been reported so far. Even so, the company decided to act early to reduce any possible risk to consumers.
Quality Issue Found in Key Ingredient
Nestlé traced the issue to a quality concern in arachidonic acid oil. Manufacturers widely use this ingredient in infant nutrition products. After detecting the problem, Nestlé immediately launched detailed testing.
The company tested all oil batches and related blends used in potentially affected products. These tests pointed to a possible risk of cereulide contamination. Certain strains of the Bacillus cereus bacterium produce this toxin.
Food safety experts warn that cereulide resists heat. Therefore, boiling water or standard formula preparation cannot neutralize it. As a result, even properly prepared formula could carry risks if contaminated.
Britain’s Food Standards Agency explained that the toxin can cause rapid symptoms. These may include nausea, vomiting, and abdominal cramps. Infants remain especially vulnerable due to their developing bodies.
European Markets Impacted by the Recall
Nestlé recalled the affected products in Austria, Denmark, Finland, Germany, Ireland, Italy, Switzerland, and the United Kingdom. The company published detailed batch numbers for each market. Parents and caregivers have been advised to stop using the listed products immediately.
In response, Nestlé activated customer support channels across Europe. The company is offering refunds or replacements to affected families. At the same time, it is working to limit supply disruptions in stores.
Austria’s health ministry described the recall as unusually large. Officials said it could involve more than 800 products from over 10 factories. Nestlé has not confirmed these figures but acknowledged the scale of the action.
Factory Review and Leadership Challenges
Nestlé identified the potential risk at one of its factories in the Netherlands. After discovering the issue, the company strengthened internal controls and monitoring processes.
The recall poses a challenge for CEO Philipp Navratil, who is leading a company-wide portfolio review. He aims to drive growth following recent management changes. Despite this setback, Nestlé reiterated its commitment to food safety and transparency.
The company stated that consumer protection remains its top priority. It also pledged continued cooperation with regulators and health authorities across Europe.
